CAS 41859-67-0
:Bezafibrate
Description:
Bezafibrate is a pharmaceutical compound primarily used as a lipid-lowering agent, particularly in the treatment of dyslipidemia. It belongs to the class of fibrates, which are known to reduce triglyceride levels and increase high-density lipoprotein (HDL) cholesterol. The chemical structure of bezafibrate features a phenoxy group and a carboxylic acid moiety, contributing to its pharmacological activity. It is typically administered orally and is well-absorbed in the gastrointestinal tract. Bezafibrate functions by activating peroxisome proliferator-activated receptors (PPARs), which play a crucial role in lipid metabolism. Its therapeutic effects include lowering low-density lipoprotein (LDL) cholesterol and triglycerides while enhancing HDL cholesterol levels. Common side effects may include gastrointestinal disturbances, muscle pain, and liver enzyme alterations. Due to its efficacy in managing lipid profiles, bezafibrate is often prescribed in conjunction with lifestyle modifications for patients at risk of cardiovascular diseases. As with any medication, monitoring and consultation with a healthcare provider are essential to ensure safety and effectiveness.
Formula:C19H20ClNO4
InChI:InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)
InChI key:InChIKey=IIBYAHWJQTYFKB-UHFFFAOYSA-N
SMILES:C(NCCC1=CC=C(OC(C(O)=O)(C)C)C=C1)(=O)C2=CC=C(Cl)C=C2
Synonyms:- 2-(4-{2-[(4-Chlorobenzoyl)Amino]Ethyl}Phenoxy)-2-Methylpropanoic Acid
- Befizal
- Benzafibrate
- Benzofibrate
- Bezafibrat
- Bezafibrato
- Bezalip
- Bezatol
- Bm 15075
- Cedur
- Difaterol
- Lysolecithin, hydrogenated
- Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 18 products.
Bezafibrate
CAS:Formula:C19H20ClNO4Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:361.82Bezafibrate, 98+%
CAS:<p>A peroxisome proliferator-activated receptor agonist and hypolipidemic agent</p>Formula:C19H20ClNO4Purity:98+%Molecular weight:361.82Bezafibrate
CAS:BezafibrateFormula:C19H20ClNO4Purity:99.3%Color and Shape:WhiteMolecular weight:361.10809BEZAFIBRATE CRS
CAS:<p>BEZAFIBRATE CRS</p>Formula:C19H20ClNO4Color and Shape:Crystalline Powder. White. Whitish. Powder.Molecular weight:361.8194Ref: IN-DA003O6M
1g29.00€5g28.00€10g50.00€15g58.00€25g68.00€50g119.00€75g139.00€100g169.00€500g626.00€100mg25.00€Bezafibrate
CAS:<p>Bezafibrate (BM15075) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES.</p>Formula:C19H20ClNO4Purity:99.56% - 99.82%Color and Shape:SolidMolecular weight:361.822-(4-(2-(4-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropanoic Acid
CAS:2-(4-(2-(4-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropanoic AcidPurity:98%Molecular weight:361.82g/molBezafibrate
CAS:Formula:C19H20ClNO4Purity:≥ 98.0%Color and Shape:White to off-white crystalline powderMolecular weight:361.82Bezafibrate 100 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C19H20ClNO4Color and Shape:ColourlessMolecular weight:361.82Bezafibrate
CAS:<p>Applications Bezafibrate is antilipemic drug.<br>References Zimmerman, R., et al.: Atherosclerosis 29, 477 (1978); Monk, J.P., et al.: Drugs, 33, 539 (1987);<br></p>Formula:C19H20ClNO4Color and Shape:WhiteMolecular weight:361.82Bezafibrate - Bio-X ™
CAS:<p>Bezafibrate is an antilipemic agent that is used in the management of primary and secondary hyperlipidaemia. This mechanism of action for this drug is not well known however it is generally accepted that this drug is an agonist of Peroxisome proliferator-activated receptor (PPAR-alpha). This drug aids in lowering cholesterol level and triglycerides.</p>Formula:C19H20ClNO4Purity:Min. 95%Color and Shape:PowderMolecular weight:361.82 g/molBezafibrate
CAS:<p>Peroxisome proliferator-activated receptor agonist; hypolipidemic drug</p>Formula:C19H20ClNO4Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:361.82 g/mol
